ERIKA SELA

INNOVATEC (SPAIN)

SRTD II and EU-Jordan Net II Workshop, Amman (Jordan), 23-24 March 2015

CONTENTS OF THE PRESENTATION

• A short introduction of myself and my work in the Spanish

company INNOVATEC

• My experience in participating in framework programmes

(FP7 & H2020), and some ideas on international

cooperation activities.

• Advises and ideas to help Jordanian researchers to

enhance and strengthen their cooperation with European

counterparts, based on my experience and know-how of

European programmes and international R&D

collaboration.

INNOVATEC is an independent Spanish firm, established in 1999,

specialized in science, technology and innovation. We provide

qualified and tailor-made consultancy services in the field of Research,

Development & Innovation to public authorities, companies and

research organizations. Our main areas of work are:

Coordination and partnering in EU funded projects (Public health

research, R&D policy, RRI, Research impact,..).

Developing and implementing Monitoring and Evaluation (M&E)

methodologies and tools for R&D and innovation (policies,

programmes and projects).

Support Regional Innovation Strategies (RIS3) plans.

Promoting Responsible Research and Innovation (RRI) in

research institutions.

Dissemination plans and stakeholder analysis for research actions.

EXPERIENCE IN EUROPEAN PROJECTS AS COORDINATORS

H2020: RegHealth-RI: The European Regions Network for Health Research & Innovation.

(Nov 2014-Oct 2017). http://www.rhing-net.eu/reghealth-ri/

FP7: EVAL-HEALTH: Developing and Testing of New Methodologies to Monitor and

Evaluate Health Related EU-Funded Interventions in Cooperation Partner Countries.

Jan 2013 - Oct 2014. www.eval-health.eu

FP7. EUROECOTOX: European Network for Alternative Testing Strategies in

Ecotoxicology. Dec 2010 -Nov 2012 ZF Biolabs. https://sites.google.com/a/euroecotox.eu/networkeuroecotox/HOME

AS PARTNERS

H2020: COLUMBUS: Monitoring, Managing and Transferring Marine and Maritime

Knowledge for Sustainable Blue Growth. Mar 2015-Feb 2018.

H2020: HEIRRI: Higher education institutions and responsible research and Innovation.

Under grant agreement negotiation.

FP7 EU-LAC Health: Defining a Roadmap for Cooperative Health Research between the

EU and Latin America-Caribbean countries: a Policy Oriented Approach. Oct 2011-Sept

2016. www.eulachealth.eu

DEVELOPING AND TESTING OF NEW METHODOLOGIES TO

MONITOR AND EVALUATE HEALTH RELATED EU-FUNDED

INTERVENTIONS IN COOPERATION PARTNER COUNTRIES

COLLABORATIVE RESEARCH PROJECT. Specific International Cooperation Action

funded by the 7TH FRAMEWORK PROGRAMME OF THE EUROPEAN COMMISSION.

INTERNATIONAL PUBLIC HEALTH

EVAL-HEALTH PROJECT

• ANALYSIS OF THE ROLE OF EVIDENCES IN HEALTH POLICY

DEVELOPMENT IN LOW AND MIDDLE-INCOME COUNTRIES: The aim of

this research is to identify and analyze the role of different types of

evidences in health policy in two countries (India and Nigeria), including

research results.

• DEVELOPMENT AND TESTING OF A NEW METHODOLOGY TO

MONITOR AND EVALUATE THE IMPACT OF RESEARCH PROJECTS:

The main goal of this research is to develop and validate a new

methodology to support the Directorate-General for Research and

Innovation of the European Commission in their task to monitor and assess

the impact of research projects that have been funded in the area of

International Public Health.

EVAL-HEALTH RESEARCH COMPONENTS

EVAL-HEALTH PROJECT PARTNERS:

1. INNOVATEC (Spain) Coordinator

2. African Union New Partnership for Africa’s Development (South Africa)

3. University of Leeds (UK)

4. Royal Tropical Institute (Netherlands)

5. Institute for Health and Tropical Medicine (Portugal)

6. Mahidol University (Thailand)

7. Association for Stimulating Know-How (India)

8. University of Nigeria, Enugu Campus (Nigeria)

9. Rosario University (Colombia) www.eval-health.eu

EVAL-HEALTH IN NUMBERS

Duration: 46 months

Nº of researchers: 24-30 - PM effort: 349

Nº face to face project meetings: 8

Nº dissemination activities: 17

Meetings with the EC: 6

Peer review publications: 1 and 4-6 (under preparation)

Policy Briefs: 8

Periodic reports (technical and financial): 3 + final report

Total project cost: 3,48 Mill EUR - Total EU contribution: 2, 86 Mill EUR

EU-LAC HEALTH: Defining a Roadmap for cooperative health research between the EU and Latin America-Caribbean countries: a policy-oriented approach (www.eulachealth.eu)

Explore, with policy-makers and other stakeholders, how to best coordinate

health research policies and funding between EU and LAC.

Establish a consensus Roadmap for cooperative health research for

collaboration between the EU and LAC regions.

Promote the creation of a Coordinating Body to develop the Roadmap.

Disseminate the project results to relevant stakeholders to increase and

improve EU-LAC cooperation in health research.

HEALTH RESEARCH IN THE HORIZON 2020 PROGRAMME

INTERNATIONAL COLLABORATION IN H2020

HORIZON 2020 is open to legal entities from across the world

JORDAN is one of the countries automatically eligible for

funding in H2020.

In addition to this general openness of most Horizon 2020 calls

to non-EU researchers, many calls particularly encourage

cooperation with non-EU partners. In the H2020 Work

programme 2014-2015, there are a total of 13 topics which

encourage cooperation (or even include it as an eligibility

criteria) with the SOUTHERN MEDITERRANEAN COUNTRIES

(Algeria, Morocco, Egypt, Israel, JORDAN, Lebanon, Libya,

Palestine, Tunisia and Syria). None of these topics is from the

area of Health.(S. Challenge 1).

FUNDING OPTIONS FOR HEALTH RESEARCH GROUPS

BASIC RESEARCH: Career development grants in Europe

European Research Council (ERC) and Marie Marie SklodowskaCurie Action (MSCA).

BASIC AND APPLIED RESEARCH & INNOVATION : H2020 CALLS Societal Challenge 1: Health, demographic change and wellbeing

Work programme 2014-2015: last calls for 2015 health close next 21 April

Work programme 2016-2017, to be adopted in the third quarter 2015.

Marie Skłodowska-Curie Research and Innovation Staff Exchange (RISE): short-term mobility (secondment = exchanges) of research and innovation staff at all career levels, including post-docs, administrative and technical staff. Deadline Date28-04-2015

http://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/9079-msca-rise-2015.html

BENEFITS FROM PARTICIPATING IN EU COLLABORATIVE RESEARCH PROJECTS

SHARING OF KNOWLEDGE, SKILLS AND

TECHNIQUES

TACIT KNOWLEDGE

TRANSFER

LEARNING SOCIAL AND

MANAGEMENT SKILLS

SOURCE OF CREATIVITY

INTELLECTUAL COMPANIONSHIP

CREATER SCIENTIFIC VISIBILITY

POOLING EQUIPMENT

CATALYSING NEW NETWORK RELATIONS

… BUT THERE ARE ALSO SOME COSTS

FINDING COLLABORATIVE

PARTNERS

TIME IN PREPARING A

JOINT PROPOSAL

INCREASED ADMINISTRATION

AND MANAGEMENT

RECONCILING DIFFERENT INTERESTS,

CULTURES AND SYSTEMS

LOW SUCESS RATES

SOME DATA FROM PREVIOUS FRAMEWORK PROGRAMMES – funded health projects with

Jordan partners

FP 7 (2007-2013) HEALTH PROGRAMME. AREA 3.4 International

public health & health systems

• RESCAP-MED - NCDs and their social determinants in Mediterranean partner

countries: building sustainable research capacity for effective policy intervention.

Jordan partner: JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY

FP6 (2002-2006) Support to International Cooperation (INCO) B.3

HEALTH

• BEDOUIN HEALTH - Improving access to and quality of reproductive and child health

care to marginal peoples:Bedouin in Jordan and Syria. Partner: Philadelphia University

• MEDGENET - Euro-Mediterranean Network for Genetic Services. Partner: National

Center For Diabetes, Endocrine And Genetic Diseases

• LEISH-MED - Monitoring risk factors of spreading of leishmaniasis around the

Mediterranean basin. Partner: Dept. Biological Sciences, Yarmouk University

OPTIONS FOR JORDAN HEALTH RESEARCH GROUPS TO PARTICIPATE IN H2020 CALLS -1

READ THOROUGHLY the Biannual work programme for

Societal challenge 1 and look for topic(s) in which your

research work and expertise fits. If topics are found:

1. Try to find someone from a EU member state who can

coordinate and who will be willing to invite you to join the

consortium.

2. Find a consortium already set up and see if you can join.

3. Coordinate a proposal (Only possible for very limited

cases, topics specifically requesting international

coordination).

OPTIONS FOR JORDAN HEALTH RESEARCH GROUPS TO PARTICIPATE IN H2020 CALLS -2

CONTACTING LOCAL NCPS THAT CAN DISSEMINATE YOURINTEREST IN TOPICS

NETWORKING WITH EUROPEAN RESEARCH GROUPS:

Jordanian researchers working in Europe (need to be identified)

Social media (LinkedIn groups H2020)

Networking, Brokerage events and Conferences organized in Europe

Jordan MSCA grantees can be a good link to EU research groups.

Participate in international programmes funded by European Countries (ie. Programme for Global Health and Vaccination Research –GLOBVAC – Norway)

Participate in multilateral health initiatives: Global Alliance for Chronic diseases, GLOBE network

OPTIONS FOR JORDAN HEALTH RESEARCH GROUPS TO PARTICIPATE IN H2020 CALLS -3

MAKE YOUR RESEARCH RESULTS VISIBLE:

Open Access Journals: PLoS ONE

Open Access repositories: Research gate, Fig share,

PUBLISH PROFILES AND PROJECT INTEREST:

euMatch 2.0 Partner Search and Matchmaking platform

LOOK FOR PROJECTS IN CORDIS TO FIND PARTNERS

http://cordis.europa.eu/projects/home_en.html

euMatch 2.0 Partner Search and Matchmaking platform

http://mm.fitforhealth.eu

FINAL REFLECTIONS - I

International Collaborative research is growing as

results of the need to address global health challenges

with large interdisciplinary, multinational projects.

H2020 is the biggest research programme funding

collaborative research in health (7,5 Bill EUR)

In H2020 International partners are welcome but they

need to contribute with excellent science and expertise.

More difficulties for Low and Middle income countries

as there are no specific programmes for international

collaboration and international calls (around 20% in 1st. WP) encourage but not oblige international participation.

FINAL REFLECTIONS - II

Bilateral projects such as EU Jordanet II and SRTD-II can stimulate the policy dialogue with the EU and contribute towards an increased visibility of Jordan researchers and institutions.

Priorities for future cooperation with the EU must include the regional component. The Euro Mediterranean Group of Senior Officials in Research and Innovation (EU-MEd GSO) can play a central role in stimulating the Euro-Mediterranean cooperation in health research and Innovation. Shared health problems such as rare disease, infectious diseases and NCDs are priority areas for collaboration and effort should be placed towards promoting topics in future H2020 programmes specifically addressing research collaboration between both regions in this fields.

SUGGESTED REFERENCES

HORIZON 2020, Health, Demographic change and wellbeing http://ec.europa.eu/programmes/horizon2020/en/h2020-section/health-demographic-change-and-wellbeing

Report from the Commission to the European parliament, the Council, the European Economic and Social Committee and the Committee of the Regions. Report on the Implementation of the strategy for international cooperation in research and innovation COM(2014) 567 final http://ec.europa.eu/research/iscp/pdf/policy/progress_report_sep-2014.pdf

Roadmap for cooperation in research and innovation between the Southern Mediterranean and the European Union http://ec.europa.eu/research/iscp/pdf/policy/annex_roadmaps_sep-2014.pdf

Global Link for Online Biomedical Expertise (GLOBE) http://www.globe-network.org/en/about-globe

GLOBAL ALLIANCE FOR CHRONIC DISEASE http://www.gacd.org/

Programme for Global Health and Vaccination Research – GLOBVAC http://www.forskningsradet.no/prognett-globvac/Home_page/1224697869238

THANK YOU VERY MUCH!

ERIKA SELA

INNOVATEC

Erika.sela@innovatec.es

www.innovatec.es